Nils Martin Krantz
Chief Executive Officer at SMART EYE AB
Net worth: 8 M $ as of 30/04/2024
Nils Martin Krantz active positions
| Companies | Position | Start | End |
|---|---|---|---|
| SMART EYE AB | Chief Executive Officer | 01/01/1999 | - |
| Founder | 01/01/1999 | - | |
| Public Communications Contact | 01/01/1999 | - | |
Neoeye AB
 Neoeye AB Electronic Equipment/InstrumentsElectronic Technology Neoeye AB develops and designs sensor solutions for HMI applications. The private company is based in Stockholm, Sweden. | Director/Board Member | - | - |
1928diagnostics AB
 1928diagnostics AB Medical SpecialtiesHealth Technology 1928diagnostics AB develops diagnostic software solutions for bacterial infections. It delivers extended resistance profiles and bacterial identification. The firm replaced traditional bacterial culturing methods and develops a personalized medicine addressing to antibiotic resistance. The company was founded by Susanne Staaf and Kristina Lagerstedt in 2014 and is headquartered in Gothenburg, Sweden. | Director/Board Member | - | - |
Career history of Nils Martin Krantz
Training of Nils Martin Krantz
| Chalmers University of Technology | Graduate Degree |
Statistics
International
| Sweden | 5 |
Operational
| Director/Board Member | 2 |
| Chief Executive Officer | 1 |
| Founder | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
| Electronic Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| SMART EYE AB | Health Technology |
| Private companies | 2 |
|---|---|
Neoeye AB
Neoeye AB Electronic Equipment/InstrumentsElectronic Technology Neoeye AB develops and designs sensor solutions for HMI applications. The private company is based in Stockholm, Sweden. | Electronic Technology |
1928diagnostics AB
1928diagnostics AB Medical SpecialtiesHealth Technology 1928diagnostics AB develops diagnostic software solutions for bacterial infections. It delivers extended resistance profiles and bacterial identification. The firm replaced traditional bacterial culturing methods and develops a personalized medicine addressing to antibiotic resistance. The company was founded by Susanne Staaf and Kristina Lagerstedt in 2014 and is headquartered in Gothenburg, Sweden. | Health Technology |
- Stock Market
- Insiders
- Nils Martin Krantz
- Experience
